Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2007
12/12/2007CN101084906A New use of medicine containing benzophen [C] anthridine alkaloid and its derivatives
12/12/2007CN101084888A Tea pigment lozenge
12/12/2007CN100354277C 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/12/2007CN100354273C Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists
12/12/2007CN100354003C Sodium acetylide/ soybean separation protein commixed gel granule preparation method
12/12/2007CN100353994C Synergistic medicinal composition
12/12/2007CN100353982C Chinese traditional medicine for treating gastropathy
12/12/2007CN100353981C Medicine for auxiliary treating hepatitis
12/12/2007CN100353978C Synergistic medicinal composition containing tiopronin and Chinese medicine extract
12/12/2007CN100353974C Composition of active ingredients of alisma rhizome, and medical application
12/12/2007CN100353968C Chinese medicine preparation for nourishing blood and tranquilizing mind and its preparation process
12/12/2007CN100353961C Compound Difengzi syrup for treating dysentery
12/12/2007CN100353954C Antiphlogistic gallbladder-benefiting soft capsule and its prepn process
12/12/2007CN100353953C Traditional Chinese medicina preparation for treating oral cavity, throat disease and its preparation method
12/12/2007CN100353945C Medicine granule kit for overcoming central fatigue
12/12/2007CN100353935C Pharmaceutical formulation contg. tolterodine and its use
12/11/2007US7307164 β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/11/2007US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity
12/11/2007US7307084 Gastric secretion inhibiting and excellent gastric and intestinal protective action properties, gastrointestinal disorder
12/11/2007US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide
12/11/2007US7307062 such as anxiety disorder, attention deficit/hyperactivity disorder, autistic disorder, bipolar disorder, major depression, mood disorder, pervasive developmental disorder, psychotic disorder and schizophrenia by administering an antimicrobial composition optionally with a probiotic mixture
12/11/2007US7306920 Gene associated with regulation of energy balance, obesity and diabetes and uses therefor
12/11/2007US7306903 Use of test cells comprising DNA defining a morphogen-responsive transcription activating element operatively associated with reporter gene, increase in expression of detectable gene product after exposing test cell to candidate compound indicates ability of compound to induce morphogen-mediated effect
12/11/2007US7306792 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors
12/11/2007CA2413510C Condensed pyrazindione derivatives
12/11/2007CA2370202C Gum pad for delivery of medication to mucosal tissues
12/11/2007CA2348735C Heterocyclic potassium channel inhibitors
12/11/2007CA2348245C Treatment of rumen acidosis with .alpha.-amylase inhibitors
12/06/2007WO2007139921A2 N-oxides of kappa opioid receptor peptides
12/06/2007WO2007139464A1 Isoindole derivatives useful for treating pain, gastrointestinal diseases and cancer
12/06/2007WO2007139211A1 Process for production of optically active piperidine compound
12/06/2007WO2007138994A1 Hsp90 inhibitor
12/06/2007WO2007138961A1 Prophylactic or therapeutic agent for disorder induced by macrophage migration inhibitory factor
12/06/2007WO2007138905A1 Intestinal eosinophil-suppressing composition
12/06/2007WO2007138705A1 Tumor suppressor
12/06/2007WO2007138171A1 Bioactive cyclic peptide
12/06/2007WO2007138047A2 Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens
12/06/2007WO2007137833A1 Specifically adapted plant-derived redox catalyst and method for the production thereof
12/06/2007WO2007137456A1 A peptide for preventing or treating liver damage and its derivant and the use
12/06/2007WO2007109592A3 Therateutic supplement using ume fruit
12/06/2007US20070281986 Methods and Compositions for Modulating Satiety
12/06/2007US20070281974 1 h-imidazole derivatives as cannabinoid receptor modulators
12/06/2007US20070281972 Pharmaceutical Composition Having Prokinetic Effect
12/06/2007US20070281970 minimal side effects, selectivity, potency, pharmacokinetics, duration of action; CNS disorders like cognitive, behavioral, mood, autonomic functions; 1-isopropyl-2-oxo-1,2-dihydro-quinoline-3-carboxylic acid {(1S,3R,5R)-8-[3-acetylamino-2-hydroxypropyl]-8-azabicyclo[3.2.1]oct-3-yl}amide
12/06/2007US20070281956 Phenylpyrimidine amines as IgE inhibitors
12/06/2007US20070281926 Rectal Composition
12/06/2007US20070281919 Aminothiazole Derivatives And Their Use As CRF Receptor Ligands
12/06/2007US20070281911 Use of Adefovir or Tenofovir for Inhibiting Mmtv-Like Viruses Involved in Breast Cancer and Primary Biliary Cirrhosis
12/06/2007US20070280958 homodimer-forming chemokines such as Chemokine (C-C motif) ligand 2 (CCL2) having a single amino acid substitution in the dimerization interface that alters the pattern of hydrogen bonds; for inflammatory, autoimmune, or infectious diseases
12/06/2007US20070280949 Combination Therapy for Gastroenteric Diseases Caused by Microorganisms
12/06/2007US20070280912 Treatment of irritable bowel syndrome using probiotic composition
12/06/2007US20070280886 Diagnostics and Therapeutics for Diseases Associated with Adrenomedullin Receptor (Amdr)
12/06/2007DE102006026026A1 Arzneimittel Drug
12/06/2007CA2653805A1 Intestinal eosinophil-suppressing composition
12/06/2007CA2653319A1 Hsp90 inhibitor
12/06/2007CA2653077A1 N-oxides of kappa opioid receptor peptides
12/06/2007CA2652735A1 Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens
12/06/2007CA2652044A1 Pyrrolopyrimidine compounds and their uses
12/06/2007CA2651368A1 Tumor suppressor
12/05/2007EP1862463A1 Pyrimidine compound crystal or amorphous form and process for producing the same
12/05/2007EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases
12/05/2007EP1862444A2 Ether compounds, compositions, and uses thereof
12/05/2007EP1862168A1 Method of treating liver cancer
12/05/2007EP1861391A1 Substituted sulfoxide compounds, methods for preparing the same and use thereof
12/05/2007EP1861169A2 Method and composition for treating mucosal disorders
12/05/2007EP1861101A2 Use of amides of sulfadimidine for the treatment of intestinal diseases in veterinary science
12/05/2007EP1861095A1 Derivatives of imidazo(1,2-a)pyridine useful as medicaments for treating gastrointestinal diseases
12/05/2007EP1861091A1 Compounds having lipid lowering properties
12/05/2007EP1861072A2 Nanocells for diagnosis and treatment of diseases and disorders
12/05/2007EP1485359B1 Sodium channel blockers
12/05/2007EP1433479B1 Appetite-stimulating agents and remedies for anorexia
12/05/2007EP1404324B1 Prodrugs of gaba analogs, compositions and uses thereof
12/05/2007EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1368318B1 Calcilytic compounds
12/05/2007EP1353681B1 Bifidobacteria capable of preventing diarrhea
12/05/2007EP1248599B1 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
12/05/2007EP1202705B1 Composition for treating dentin hypersensitivity
12/05/2007EP1173252B1 Products for brachytherapy and methods for their production
12/05/2007EP0918754B1 Anthranilic acid diamides derivatives, their preparation and pharmaceutical use as anti-gastrin agents
12/05/2007CN101084005A Compounds for flaviviridae treatment
12/05/2007CN101083994A Heterocyclic derivatives and their use as therapeutic agents
12/05/2007CN101083993A Heterocyclic derivatives and their use as therapeutic agents
12/05/2007CN101081871A Protein transduction field 4-apopain fusion protein (PTD4-Apoptin) and preparation method and application thereof
12/05/2007CN101081861A Glycyrrhizic acid double salt and preparation thereof
12/05/2007CN101081853A 7-phenylpyrazolopyridine compounds
12/05/2007CN101081293A Capsules preparations for preventing and treating hepatic disease by dispersing blood-stasis of portal vein
12/05/2007CN101081290A Chinese medicinal material preparation for relieving pain
12/05/2007CN101081289A Medicine for relieving the flatulence and stomach-ache
12/05/2007CN101081288A Health-care bag for baby
12/05/2007CN101081287A Health products Chinese medicinal materials health products for relieving hepatitis
12/05/2007CN101081283A Health-care tea for body and stomach strengthening and its preparing process
12/05/2007CN101081282A Chinese medicinal materials health products for treating aural vertigo
12/05/2007CN101081274A Chinese medicinal materials composition for treating gastroptosis and the processing
12/05/2007CN101081273A Chinese medicinal materials for treating dizziness
12/05/2007CN101081266A Chinese medicinal material pills for treating halitosis
12/05/2007CN101081259A Chinese medicinal materials decoction for treating top-left fenghuo tooth pain
12/05/2007CN101081257A Chinese medicinal material preparations for treating dysentery
12/05/2007CN101081251A Polygonum multiflorum thunb processing method
12/05/2007CN101081240A Medicinal composition of oxymatrine and polysaccharide